Mundipharma
Mundipharma is the privately held network of companies associated with the Sackler family outside the United States, known for opioid pain medicines used in cancer care and, in Europe, for oncology products such as the antifungal and haematology lines it licenses.
Overview
Mundipharma comprises independent associated companies, with the German business in Limburg an der Lahn founded in 1967, that market pain medicines including controlled-release oxycodone and buprenorphine, as well as oncology, haematology and anti-infective products in many countries. Its research arm, Mundipharma Research GmbH, has led phase 3 trials in cancer pain and supportive care registered on ClinicalTrials.gov.
Similar pages
not linked directly; found by shared links- CompanyCSL Limited
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyD3 Bio (Wuxi)
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyDong-A ST
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyEndo (now Keenova Therapeutics and Par Health)
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyEurofarma
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyGrifols
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyInsys Therapeutics
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyIntra-IMMUSG
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.